Outlook Therapeutics, Inc. (OTLK) Q3 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello everyone and welcome to the Outlook Therapeutics third quarter fiscal year 2026 corporate update conference call and webcast. As a brief reminder, all participants are currently in a listen-only mode. If anyone requires operator assistance during the event, please press star zero on your telephone keypad. Following the presentation, there will be a question and answer session. Note that this webcast is being recorded and a replay will be made available on the company's website following the end of the event. At this time, I'd like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations, plans, or future projections. These are forward-looking statements and involve risk and uncertainties. As a result, you should not place undue reliance on any forward-looking statements, some of the factors that could cause actual results different materially from those contemplated by such forward-looking statements and discussed in the periodic reports Outlook Therapeutics files and Securities and Exchange Commissions. These documents are available in the investor sections of the company's website and on the Security Exchange Commission's website. We encourage you to review these documents carefully Additionally, certain information contained in the website relates to or is based on studies, publications, surveys, and other data obtained from third-party sources and the company's own estimates and research. While the adequacy, fairness, and accuracy of the completeness of or that any independent source has verified any information obtained from the third-party sources. Joining us on today's call from the Outlook Therapeutics Leadership Team are Bob Jahr, President and Chief Executive Officer, and Lawrence Kenyon, E...